Tonia Antoniazzi

No one in either my department or the Government Equalities Unit has had discussions on this topic with either World Rugby or the Rugby Football Union.

Officials in my department meet regularly with Sport England to discuss a range of issues related to diversity and inclusion across all sports, including transgender and non-binary participation, and the overarching guidance that Sport England is involved in providing to the grassroots sport sector. These discussions are general and do not focus on specific types of sport, such as contact sport.

My department has not had discussions on this topic with either World Rugby or the England Rugby Football Union. Officials in my department meet regularly with Sport England to discuss a range of issues related to diversity and inclusion in sport, including transgender and non-binary participation.

My department has not had discussions on this topic with either World Rugby or the England Rugby Football Union. Officials in my department meet regularly with Sport England to discuss a range of issues related to diversity and inclusion in sport, including transgender and non-binary participation.

My department has not had discussions on this topic with either World Rugby or the England Rugby Football Union. Officials in my department meet regularly with Sport England to discuss a range of issues related to diversity and inclusion in sport, including transgender and non-binary participation.

The Government’s vaccines portfolio ensures we have the best chance of accessing a safe and effective vaccine for people in the UK as soon as one becomes available. We are also working on deployment plans in the event that a safe, effective vaccine is discovered.

We are vigorously pursuing efforts on vaccines, therapeutics and mass testing to return conditions to normal as soon as possible. In terms of a vaccine, there are several encouraging trials but it is likely to be well into 2021 until one can be widely deployed. Our strategy will continue to be shaped by the work of our brilliant scientists.

We know this is a challenging period for all sports and the Government remains committed to supporting our elite athletes. Olympic and Paralympic sport is not immune from the impact of Covid-19 and we will continue to work with UK Sport and other sports bodies in ensuring that our elite athletes are well supported in this difficult period to ensure that Team GB and ParalympicsGB are ready for the Tokyo Games and other world wide sporting events when they do take place in 2021.

The English Institute of Sport’s world-class support for our athletes has been maintained during the current epidemic. Team GB’s historic medal haul in Rio was an amazing achievement and our athletes made the country incredibly proud. I am confident that this success will continue through to Tokyo next summer.

The Government’s vaccines portfolio ensures we have the best chance of accessing a safe and effective vaccine for people in the UK as soon as one becomes available. We are also working on deployment plans in the event that a safe, effective vaccine is discovered.

We are vigorously pursuing efforts on vaccines, therapeutics and mass testing to return conditions to normal as soon as possible. In terms of a vaccine, there are several encouraging trials but it is likely to be well into 2021 until one can be widely deployed. Our strategy will continue to be shaped by the work of our brilliant scientists.

We know this is a challenging period for all sports and the Government remains committed to supporting our elite athletes. Olympic and Paralympic sport is not immune from the impact of Covid-19 and we will continue to work with UK Sport and other sports bodies in ensuring that our elite athletes are well supported in this difficult period to ensure that Team GB and ParalympicsGB are ready for the Tokyo Games and other world wide sporting events when they do take place in 2021.

The English Institute of Sport’s world-class support for our athletes has been maintained during the current epidemic. Team GB’s historic medal haul in Rio was an amazing achievement and our athletes made the country incredibly proud. I am confident that this success will continue through to Tokyo next summer.

The Government’s vaccines portfolio ensures we have the best chance of accessing a safe and effective vaccine for people in the UK as soon as one becomes available. We are also working on deployment plans in the event that a safe, effective vaccine is discovered.

We are vigorously pursuing efforts on vaccines, therapeutics and mass testing to return conditions to normal as soon as possible. In terms of a vaccine, there are several encouraging trials but it is likely to be well into 2021 until one can be widely deployed. Our strategy will continue to be shaped by the work of our brilliant scientists.

We know this is a challenging period for all sports and the Government remains committed to supporting our elite athletes. Olympic and Paralympic sport is not immune from the impact of Covid-19 and we will continue to work with UK Sport and other sports bodies in ensuring that our elite athletes are well supported in this difficult period to ensure that Team GB and ParalympicsGB are ready for the Tokyo Games and other world wide sporting events when they do take place in 2021.

The English Institute of Sport’s world-class support for our athletes has been maintained during the current epidemic. Team GB’s historic medal haul in Rio was an amazing achievement and our athletes made the country incredibly proud. I am confident that this success will continue through to Tokyo next summer.

The Government is committed to working with the whole of sport to ensure it is diverse and inclusive, and discusses equality as part of regular engagement with the sector

As announced in July 2020, UK Sport and Sport England are carrying out a review of the Code for Sports Governance to look at areas where it would benefit from further development, including around equality, diversity and inclusion.

The latest available information on the number of people on Universal Credit who are in employment in Great Britain, by country, is published and can be found at:

https://stat-xplore.dwp.gov.uk/.

Guidance on how to extract the information required can be found at:

https://stat-xplore.dwp.gov.uk/webapi/online-help/Getting-Started.html

Universal Credit statistics for Northern Ireland are published by the Department for Communities here:

https://www.communities-ni.gov.uk/articles/universal-credit-statistics

The information requested is not readily available and could only be provided at disproportionate cost.

As both the Prime Minister and Chancellor have made clear, the Government will do whatever it takes to support people affected by COVID 19 and we have been clear in our intention that everyone should be supported to do the right thing.

From 1 January, United Kingdom prescriptions, including those in Northern Ireland, will no longer be valid in the Netherlands. There are a small number of patients who rely on certain unlicensed cannabis-based medicines that are supplied in the Netherlands against UK prescriptions, almost all of which are private prescriptions.

The Department, supported by the British Embassy to The Hague, has reached an agreement with the Dutch Government to allow the continued supply of Bedrocan oils, a form of unlicensed medicinal cannabis, against United Kingdom prescriptions for existing patients until 1 July 2021. The medicines supply chain has ensured that there continues to be good supply of licensed and unlicensed cannabis-based medicines after the transition period.

The Written Ministerial Statement of 26 January (HCWS734) provided an update on action taken by the Government on supply from the Netherlands and next steps to establish a more permanent solution.

From 1 January, United Kingdom prescriptions, including those in Northern Ireland, will no longer be valid in the Netherlands. There are a small number of patients who rely on certain unlicensed cannabis-based medicines that are supplied in the Netherlands against UK prescriptions, almost all of which are private prescriptions.

The Department, supported by the British Embassy to The Hague, has reached an agreement with the Dutch Government to allow the continued supply of Bedrocan oils, a form of unlicensed medicinal cannabis, against United Kingdom prescriptions for existing patients until 1 July 2021. The medicines supply chain has ensured that there continues to be good supply of licensed and unlicensed cannabis-based medicines after the transition period.

The Written Ministerial Statement of 26 January (HCWS734) provided an update on action taken by the Government on supply from the Netherlands and next steps to establish a more permanent solution.

From 1 January, United Kingdom prescriptions, including those in Northern Ireland, will no longer be valid in the Netherlands. There are a small number of patients who rely on certain unlicensed cannabis-based medicines that are supplied in the Netherlands against UK prescriptions, almost all of which are private prescriptions.

The Department, supported by the British Embassy to The Hague, has reached an agreement with the Dutch Government to allow the continued supply of Bedrocan oils, a form of unlicensed medicinal cannabis, against United Kingdom prescriptions for existing patients until 1 July 2021. The medicines supply chain has ensured that there continues to be good supply of licensed and unlicensed cannabis-based medicines after the transition period.

The Written Ministerial Statement of 26 January (HCWS734) provided an update on action taken by the Government on supply from the Netherlands and next steps to establish a more permanent solution.

From 1 January, United Kingdom prescriptions, including those in Northern Ireland, will no longer be valid in the Netherlands. There are a small number of patients who rely on certain unlicensed cannabis-based medicines that are supplied in the Netherlands against UK prescriptions, almost all of which are private prescriptions.

The Department, supported by the British Embassy to The Hague, has reached an agreement with the Dutch Government to allow the continued supply of Bedrocan oils, a form of unlicensed medicinal cannabis, against United Kingdom prescriptions for existing patients until 1 July 2021. The medicines supply chain has ensured that there continues to be good supply of licensed and unlicensed cannabis-based medicines after the transition period.

The Written Ministerial Statement of 26 January (HCWS734) provided an update on action taken by the Government on supply from the Netherlands and next steps to establish a more permanent solution.

The National Health Service and the Department do not routinely collect data on the number of people who sought medical intervention to reverse or undo a previous medical intervention for the alleviation of gender dysphoria.

The Department has spent £9,000 on consultancy fees since 1 March 2020 in respect of communications related activities. This cost reflects the consultancy spend recorded on the digital, engagement and content cost centre. It is possible further communications related consultancy costs have been incurred in other areas of Departmental business however these are not separately identifiable.

In terms of media buying, the Department has spent £10.7 million since 1 March 2020. For spend on communications, advertising and marketing, the information is not collected in the format requested.

The Department has spent £9,000 on consultancy fees since 1 March 2020 in respect of communications related activities. This cost reflects the consultancy spend recorded on the digital, engagement and content cost centre. It is possible further communications related consultancy costs have been incurred in other areas of Departmental business however these are not separately identifiable.

In terms of media buying, the Department has spent £10.7 million since 1 March 2020. For spend on communications, advertising and marketing, the information is not collected in the format requested.

The Secretary of State for Health and Social Care has not made such an assessment.

The National Health Service published the interim NHS People Plan on 3 June 2019. It sets out the long-term vision and immediate actions to meet the challenges of supply, reform, culture and leadership.

The final NHS People Plan will be published shortly and will set out a clear framework for collective action on workforce priorities, with a focus on growing and retaining a well-skilled workforce across the whole NHS.

NHS England and NHS Improvement have asked all Cancer Alliances to help more patients and families manage the impact of cancer and its treatment on psychological and physical health over the next five years. It is the responsibility of individual Cancer Alliances to publish their plans on their websites.

Over the next five years, Cancer Alliances will be embedding personalised care interventions, which will identify and address the changing needs of cancer patients from diagnosis onwards, including psychological needs. People with long term conditions, such as cancer, have been identified as priority patients for accessing Improving Access to Psychological Therapy services. These services are being integrated with physical health services, to better align psychological therapies for mental illness within primary and secondary care pathways.

Over the next five years, Cancer Alliances will be embedding personalised care interventions, which will identify and address the changing needs of cancer patients from diagnosis onwards, including psychological needs. People with long term conditions, such as cancer, have been identified as priority patients for accessing Improving Access to Psychological Therapy services. These services are being integrated with physical health services, to better align psychological therapies for mental illness within primary and secondary care pathways.

Over the next five years, Cancer Alliances will be embedding personalised care interventions, which will identify and address the changing needs of cancer patients from diagnosis onwards, including psychological needs. People with long term conditions, such as cancer, have been identified as priority patients for accessing Improving Access to Psychological Therapy services. These services are being integrated with physical health services, to better align psychological therapies for mental illness within primary and secondary care pathways.

The Department recognises that the annual allowance may contribute to decisions from National Health Service consultants to retire early or limit their NHS commitment. The Government is listening carefully to concerns raised by senior doctors and NHS employers about the tapered annual allowance.

In September 2019 guidance was issued by NHS Employers informing employers of the short-term approaches that they could take to mitigate the effect of pension tax on their workforce this tax year. The NHS has also implemented an immediate measure to preserve clinical capacity amid the increased pressure on services during the winter period. This will compensate NHS clinicians for the effect on their pensions of annual allowance charged incurred in 2019-20.

The Department has consulted on introducing flexibility within the NHS Pension Scheme from 2019/20 to allow clinicians affected by annual allowance tax charges to reduce their pension accrual in deciles in order to manage any potential annual allowance tax charges.

As part of a wider drive to ensure the NHS has the staff it needs to meet demand and transform care, the Government is carrying out an urgent review of the pensions annual allowance taper problem that has caused some doctors to turn down extra shifts for fear of high tax bills. On 13 January, Ministers held a roundtable with the Academy of Medical Royal Colleges, the British Medical Association and other representative organisations as part of this review to find a long-term solution.

The review will consider the findings from the Department’s consultation on pension flexibility and will report at the Budget on 11 March.

The Department recognises that the annual allowance may contribute to decisions from National Health Service consultants to retire early or limit their NHS commitment. The Government is listening carefully to concerns raised by senior doctors and NHS employers about the tapered annual allowance.

In September 2019 guidance was issued by NHS Employers informing employers of the short-term approaches that they could take to mitigate the effect of pension tax on their workforce this tax year. The NHS has also implemented an immediate measure to preserve clinical capacity amid the increased pressure on services during the winter period. This will compensate NHS clinicians for the effect on their pensions of annual allowance charged incurred in 2019-20.

The Department has consulted on introducing flexibility within the NHS Pension Scheme from 2019/20 to allow clinicians affected by annual allowance tax charges to reduce their pension accrual in deciles in order to manage any potential annual allowance tax charges.

As part of a wider drive to ensure the NHS has the staff it needs to meet demand and transform care, the Government is carrying out an urgent review of the pensions annual allowance taper problem that has caused some doctors to turn down extra shifts for fear of high tax bills. On 13 January, Ministers held a roundtable with the Academy of Medical Royal Colleges, the British Medical Association and other representative organisations as part of this review to find a long-term solution.

The review will consider the findings from the Department’s consultation on pension flexibility and will report at the Budget on 11 March.

The Department recognises that the annual allowance may contribute to decisions from National Health Service consultants to retire early or limit their NHS commitments, although a precise estimate of the change in staffing levels as a result of pension tax is not available. The Government is listening carefully to concerns raised by senior doctors and NHS employers about the tapered annual allowance.

In September 2019 guidance was issued by NHS Employers informing employers of the short-term approaches that they could take to mitigate the effect of pension tax on their workforce this tax year. The NHS has also implemented an immediate measure to preserve clinical capacity amid the increased pressure on services during the winter period. This will compensate NHS clinicians for the effect on their pensions of annual allowance charges incurred in 2019-20.

The Department has consulted on introducing flexibility within the NHS Pension Scheme from 2019/20 to allow clinicians affected by annual allowance tax charges to reduce their pension accrual in deciles in order to manage any potential annual allowance tax charges.

As part of a wider drive to ensure the NHS has the staff it needs to meet demand and transform care, the Government is carrying out an urgent review of the pensions annual allowance taper problem that has caused some doctors to turn down extra shifts for fear of high tax bills. On 13 January, Ministers held a roundtable with the Academy of Medical Royal Colleges, the British Medical Association and other representative organisations as part of this review to find a long-term solution.

The review will consider the findings from the Department’s consultation on pension flexibility and will report at the Budget on 11 March.